Gerli, R., Bistoni, O., Lunardi, C., Giacomelli, R., Tomassini, C., Biagini, P. and Pitzalis, C. (1999) Soluble CD30 in early rheumatoid arthritis as a predictor of good response to second-line therapy. Rheumatology, 38, 1999, 1282-1284. doi:10.1093/rheumatology/38.12.1282

has been cited by the following article:

• TITLE: Anti-inflammatory effect of plant compositions of Tibetan medicine in vitro on early rheumatoid arthritis

  AUTHORS: L. Yu. Semenova, J. M. Salmasi, G. V. Poryadin

  KEYWORDS: Early Rheumatoid Arthritis; Subpopulation of Lymphocytes; Tibetan Medicine; Immunoregulators

  JOURNAL NAME: Health, Vol.3 No.9, September 23, 2011

  ABSTRACT: Materials and Methods: lymphocytes of 10 pa-tients having early rheumatoid arthritis (RA) (the duration of the illness was 3 - 6 months) with a marked exudational process in joints were ex-amined. The content of lymphocytes expressing the CD3, CD4, CD8, CD16, CD56, CD20, CD72, CD38, CD23, CD25, CD71, HLA-DR, CD95, CD30, CD54, mIgM, mIgG antigens was determined. Results: the “Taban-Arshan” extract corrects the changes of the immune system characterized by the evident activation of the B-cell part of the immune system and normalizes immune parameters of the lymphocytes taken from the patients with autoimmune diseases (early rheumatoid arthritis). The immunocorrective effect of the “Taban-Arshan” extract is related to its ability to suppress the lymphocyte increased activation by normalizing expression of the main activation antigens (CD23, CD25, CD71, HLA-DR, CD54).